Partillion Bioscience's Nanovial Products Available in Japan Through Distribution by Sony
Partillion Bioscience's Nanovial Products Available in Japan Through Distribution by Sony
One-line Summary: Distribution by Sony in Japan Leverages Compatibility of Nanovial Technology with Sony's Flow Cytometry Instruments
日本索尼的分銷利用Nanovial技術與索尼流式細胞儀器兼容
LOS ANGELES, July 1, 2024 /PRNewswire/ -- Partillion Bioscience Corporation ("Partillion"), a life science tools company, announced the commercial availability of its portfolio of single-cell analysis products in Japan. Partillion's Nanovial technology enables functional single-cell screens directly from secreting cells, all using standard flow cytometers and flow sorters. Nanovials are bowl-shaped hydrogel microparticles sized to fit through flow cytometry instruments. Cells are loaded into the nanoliter-scale cavities of Nanovials where their secretions can also be captured, labeled and analyzed. The products available in Japan include flexible biotinylated Nanovials for custom assay development, and two recently released products that accelerate antibody discovery from mouse antibody-secreting cells. Partillion's products have been easy to adopt across the world because they leverage standard flow cytometry instruments, with over 100 customers across academic institutions, national research centers, pharmaceutical and biotechnology companies.
2024年7月1日洛杉磯/美通社-生命科學工具公司Partillion Bioscience Corporation(以下簡稱“Partillion”)宣佈其單細胞分析產品組合在日本市場上的商業可用性。Partillion的Nanovial技術可直接從分泌細胞進行功能單細胞篩選，所有這一切都使用標準的流式細胞儀和流式分選機。Nanovials是碗狀的水凝膠微粒，尺寸適合流式細胞儀器。細胞被裝載到Nanovials的納升級空腔中，在那裏，細胞也可以被捕獲、標記和分析其分泌物。在日本可用的產品包括用於定製化合物分析的靈活生物素化Nanovials，以及從小鼠分泌抗體細胞中加速抗體發現的兩個最近推出的產品。Partillion的產品易於全球採用，因爲它們利用標準流式細胞儀器，在學術機構、國家研究中心、製藥和生物技術公司等機構中已有100多個客戶。
Sony Corporation will be the exclusive distributor of Partillion's products in Japan, which will allow Partillion to further accelerate adoption in Japan of Partillion's growing product portfolio. Products that will be distributed in Japan include Partillion's original Nanovial formulation and recently released EZM formulation, expanding compatibility to adherent cells while also improving cell recovery and secretion signal. In addition, Partillion's Antibody Discovery Kits for mouse hybridoma, plasmablasts and plasma cells will be available in Japan. These all-in-one kits provide reagents and protocols to simplify the workflow for customers to screen hundreds of thousands of antibody-secreting cells in a single day, using instruments they already have, such as Sony's flow cytometers. Live cells are recovered suitable for downstream regrowth or single-cell sequencing.
索尼公司將是Partillion在日本的獨家分銷商，這將進一步加速Partillion的產品在日本的採用，包括Partillion的原始Nanovial配方和最近推出的EZM配方，在擴展對貼壁細胞的兼容性的同時還改善了細胞回收和分泌信號。此外，Partillion的小鼠雜交瘤、漿細胞前體和漿細胞抗體發現套件也將在日本銷售。這些一體化套件提供試劑和協議，簡化了客戶在一天內篩選成千上萬個分泌抗體細胞的工作流程，使用的儀器已有的，比如索尼的流式細胞儀。存活的細胞可以恢復生長或進行單細胞測序。
"Throughout our product development we've seen fantastic compatibility of Nanovials with Sony's cell sorters and spectral analyzers," said Joe de Rutte, Co-founder and CEO of Partillion. "Our customers are often Sony customers, and we can seamlessly enable new research and drug discovery capabilities for them, creating huge cost efficiencies and value."
“在我們的產品開發過程中，我們發現Nanovials與索尼的細胞分選器和光譜分析器非常兼容，”Partillion聯合創始人兼首席執行官Joe de Rutte說。“我們的客戶常常也是索尼的客戶，我們可以無縫地爲他們提供新的研究和藥物發現能力，從而創造巨大的成本效益和價值。”
About Partillion
關於Partillion
Partillion Bioscience is a venture-backed life science company developing a next generation single-cell analysis platform. Partillion's award winning Nanovial technology enables customers to accelerate therapeutic development to address the most difficult diseases and provide advanced scientific insights. The reagent-based platform, with products available at , unlocks the ability to screen hundreds of thousands to millions of individual cells based on critical yet difficult to probe functional information all while using easy to access lab equipment – solving a major pain point in the industry. The technology underpinning Partillion's products was developed in Dino Di Carlo's lab (UCLA) and has been featured in notable journals such as Nature Nanotechnology, Nature Communications, Proceedings of the National Academy of Sciences of the USA, Science Advances, and ACS Nano and received industry accolades, winning the 2020 SLAS Innovation Award and 2022 SLAS New Product Award.
Partillion Bioscience是一家創業公司，得到風險投資，正在開發下一代單細胞分析平台。Partillion的獲獎Nanovial技術爲客戶提供了加速治療性開發，以應對最困難的疾病並提供先進的科學見解。基於試劑的平台，在解鎖基於關鍵但難以探測的功能信息進行數百萬個單個細胞篩選的能力的同時，使用易於訪問的實驗室設備-解決了業內的主要痛點。Partillion產品的技術根基是在Dino Di Carlo實驗室(加州大學洛杉磯分校)開發的，並被收錄在著名期刊Nature Nanotechnology、Nature Communications、美國國家科學院學報、Science Advances和ACS Nano中，並獲得行業認可，贏得2020年SLAS創新獎和2022年SLAS新產品獎。
SOURCE Partillion Bioscience
PARTILLION BIOSCIENCE的消息來源
譯文內容由第三人軟體翻譯。